Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.01 USD | -3.83% | -4.74% | +1.52% |
Mar. 08 | Truist Securities Adjusts Price Target on Compugen to $5 From $4, Maintains Buy Rating | MT |
Mar. 05 | Transcript : Compugen Ltd., Q4 2023 Earnings Call, Mar 05, 2024 |
Financials (USD)
Sales 2024 * | 37.9M | Sales 2025 * | 35.29M | Capitalization | 180M |
---|---|---|---|---|---|
Net income 2024 * | -13M | Net income 2025 * | -29M | EV / Sales 2024 * | 4.75 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 5.1 x |
P/E ratio 2024 * |
-15.5
x | P/E ratio 2025 * |
-7.44
x | Employees | 68 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.62% |
Latest transcript on Compugen Ltd.
1 day | -3.83% | ||
1 week | -4.74% | ||
Current month | +4.15% | ||
1 month | -11.06% | ||
3 months | -6.07% | ||
6 months | +248.35% | ||
Current year | +1.52% |
Managers | Title | Age | Since |
---|---|---|---|
Anat Cohen-Dayag
CEO | Chief Executive Officer | 57 | 01-12-31 |
Alberto Sessa
DFI | Director of Finance/CFO | 61 | 22-10-31 |
Eran Ophir
CTO | Chief Tech/Sci/R&D Officer | - | 14-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Sekhri
CHM | Chairman | 65 | 17-10-01 |
Sanford Zweifach
BRD | Director/Board Member | 68 | 18-06-10 |
Gilead Halevy
BRD | Director/Board Member | 57 | 18-06-10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 2.01 | -3.83% | 271,884 |
24-05-09 | 2.09 | -1.88% | 106,608 |
24-05-08 | 2.13 | -3.62% | 188,656 |
24-05-07 | 2.21 | +2.79% | 301,497 |
24-05-06 | 2.15 | +1.90% | 178,293 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.52% | 180M | |
+17.96% | 44.96B | |
+48.77% | 41.85B | |
+1.17% | 42.65B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- CGEN Stock